Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Advertising Agency	14.26M
Inter-Segment Elimination	-67.80M
Big Health Business	223.44M
Fast Selling Drinks	173.52M
Total	343.42M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
North China	18.42M						-	-	-	-
Central China	1.29M						-	-	-	-
East China	121.68M						-	-	-	-
South China	30.89M						-	-	-	-
Hong Kong, Macao and Taiwan	1.65M						-	-	-	-
Northwest	75.12M						-	-	-	-
Southwest	88.29M						-	-	-	-
Overseas	1.70M						-	-	-	-
China	-						233.75M	333.02M	471.12M	708.13M
Total	339.03M						233.75M	333.02M	471.12M	708.13M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error